Cibc Bancorp Usa Inc. Precigen, Inc. Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Precigen, Inc. stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 273,456 shares of PGEN stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
273,456Holding current value
$1.07 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PGEN
# of Institutions
168Shares Held
176MCall Options Held
506KPut Options Held
1M-
Third Security, LLC83.5MShares$326 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD26.5MShares$103 Million4.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.3MShares$44 Million0.03% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$40 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.94MShares$34.9 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $812M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...